What is CVE-2021-38425?

CVE-2021-38425 is a high-severity vulnerability in Eprosima Fast Dds, classified under CWE-406. CVSS score: 7.5/10. Published 2022-05-05.

How severe is CVE-2021-38425?

High severity. CVSS v3 base score is 7.5 out of 10.

Vulnerability in Eprosima Fast Dds

CVE-2021-38425

eProsima Fast DDS versions prior to 2.4.0 (#2269) are susceptible to exploitation when an attacker sends a specially crafted packet to flood a target device with unwanted traffic, which may result in a denial-of-service condition and infor…

EPSS: 0.052 (91.6th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.

Affected products

Eprosima Fast Dds — versions unspecified
Eprosima Fast_dds

Weakness classification (CWE)

CWE-406

References

ics-cert@hq.dhs.gov (x_refsource_CONFIRM, US Government Resource, Third Party Advisory)
ics-cert@hq.dhs.gov (x_refsource_CONFIRM, Product, Third Party Advisory)

Frequently asked questions

What is CVE-2021-38425?: CVE-2021-38425 is a high-severity vulnerability in Eprosima Fast Dds, classified under CWE-406. CVSS score: 7.5/10. Published 2022-05-05.
How severe is CVE-2021-38425?: High severity. CVSS v3 base score is 7.5 out of 10.